Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Biosimilars [Design Issues]

posted by M.Vasu – India, 2011-11-24 15:01 (4138 d 21:07 ago) – Posting: # 7712
Views: 5,690

Hi,

Can any one explain regarding BE study procedure for Biosimilars (Injection) in healthy subjets?

Thanks,

VM..........

Edit: Category changed. [Helmut]

Complete thread:

BiosimilarsM.Vasu 2011-11-24 14:01 [Design Issues]
- Biosimilars Helmut 2011-11-24 14:44
  - Biosimilars M.Vasu 2011-11-28 12:33
    - Healthy subjects vs. patients Helmut 2011-11-28 12:56
    - Biosimilars drgunasakaran1 2012-02-06 13:57
  - Biosimilars Ben 2011-12-16 19:04
- Biosimilars Chiku 2012-02-03 06:43
  - Biosimilars drgunasakaran1 2012-02-10 11:33
    - Biosimilars Chiku 2012-02-10 12:03
      - Biosimilars Kumarnaidu2 2021-10-22 07:53

Admin contact
22,550 posts in 4,724 threads, 1,606 registered users;
20 visitors (1 registered, 19 guests [including 5 identified bots]).
Forum time: 12:09 CET (Europe/Vienna)

If there is an exception to any rule,
and if it can be proved by observation,
that rule is wrong. Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz